Speaker illustration

Ms Natacha Bastien

Novartis Pharmaceuticals Canada Inc, Dorval (Canada)

The PARASAIL study Patient reported outcomes from the Canadian real world experience use of sacubitril/valsartan in patients with heart failure and reduced ejection fraction

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Acute heart failure (management)

Session: Acute heart failure

Thumbnail